Mbarara University of Science and Technology’s (MUST) Center for Innovation and Technology Transfer (CITT) continues to be a catalyst for groundbreaking innovations. The latest success story emerges from the realm of pharmaceutical sciences, with the approval of “DERMARLIC Tincture” by the National Drug Authority (NDA).
A Collaborative Effort
The development of DERMARLIC Tincture is a testament to the collaborative spirit at MUST. Mr. Kagimu Braize Ben, a postgraduate student, and Mr. Anyole Arthur Amule, both alumni of the Department of Pharmaceutical Sciences, spearheaded this innovative project. Their efforts were guided by the expert mentorship of Dr. Jonans Tusiimire.
CITT’s Role in Innovation
The CITT played a pivotal role in bringing this innovation to life by providing funding and support. The project was funded by CITT (Q1-2023/34) and is currently being produced at PHARMBIOTRAC, a state-of-the-art facility at MUST.
A Bright Future for DERMARLIC Tincture
With NDA approval, DERMARLIC Tincture is poised to make a significant impact on healthcare. This innovative product represents a major milestone for MUST and its CITT, solidifying the institution’s commitment to research, innovation, and societal impact.
As MUST continues to foster a culture of innovation, we can anticipate more groundbreaking developments emerging from the CITT and its talented researchers.
Congratulatory Message from the Dean, Faculty of Medicine Dr. Joseph Ngonzi, Associate Professor of obstetrics and gynaecology
On behalf of the Faculty of Medicine, I extend my heartfelt congratulations to Mr. Kagimu Braize Ben, Mr. Anyole Arthur Amule, and Dr. Jonans Tusiimire on the successful approval of DERMARLIC Tincture by the National Drug Authority. This achievement is a testament to your dedication, innovation, and hard work.
Your groundbreaking work aligns perfectly with our faculty’s mission to advance healthcare through research and innovation. This milestone not only enhances our reputation as a leading institution in pharmaceutical sciences but also promises to improve the lives of many.
I am truly inspired by your commitment to excellence. May this achievement be the first of many more to come.
Congratulatory Message from the Vice Chancellor Prof. Pauline Byakika Kibwika
I am delighted to congratulate the team behind the development of DERMARLIC Tincture on their remarkable achievement in securing NDA approval. This is a significant milestone for MUST and a testament to the innovative spirit that permeates our institution.
The successful development of DERMARLIC Tincture aligns perfectly with our university’s vision and mission. It showcases our commitment to providing quality education and research that addresses real-world challenges.
I commend the efforts of Mr. Kagimu Braize Ben, Mr. Anyole Arthur Amule, and Dr. Jonans Tusiimire. Your dedication and hard work have brought us to this momentous occasion. Congratulations once again!
Congratulatory Message from the director of CITT Dr. Medard TwinamatsikoÂ
I am very thrilled to register this great achievement as MUST for our team Demarlic Tincture! Thumbs up to Arthur, Ben and your mentor Dr. Tusiimire for achieving this milestone! Congratulations to the Faculty of Medicine.
This is no mean achievement, it has been a combination of hard work, commitment, resilience and able mentorship! It is a testament of the growth and development of the innovation ecosystem at MUST.
Next year, our target is to have more products approved and certified by NDA, UNBS and other regulatory bodies, and more Intellectual Property filed in order to secure our products presence on the market! With innovation success stories, MUST will be more competitive and relevant in enhancing pragmatic higher education. The opportunity has now been opened to you team Demarlic Tincture and there is no turning back. I wish you well as you officially hit the market! Succeed we MUST!
